GPAT
NASDAQ · N/A
Gp-Act Iii Acquisition-A
$11.07
+0.06 (+0.55%)
Open$11.07
Previous Close$11.01
Day High$11.07
Day Low$11.07
52W High$12.00
52W Low$10.57
Volume—
Avg Volume182.2K
Market Cap178.90M
P/E Ratio21.19
EPS$0.24
SectorN/A
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 208.86M | 186.14M | 170.16M |
| Net Income | 16.91M | 14.74M | 15.51M |
| Profit Margin | 8.1% | 7.9% | 9.1% |
| EBITDA | 35.39M | 34.71M | 28.86M |
| Free Cash Flow | 27.19M | 19.88M | 18.98M |
| Rev Growth | +18.7% | +1.7% | +5.6% |
| Debt/Equity | 1.10 | 1.12 | 1.24 |
N/A Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| EMAT | Evolution Metals & Technolog | $0.93 | -5.64% | — | 585.99M |
| PICS | Pics Nv | $7.42 | +6.61% | 4.1 | 961.54M |
| DMII | Drugs Made In America Acquis | $10.24 | -0.05% | 50.1 | 652.61M |
| CCCX | Churchill Capital Corp X-A | $10.08 | -5.62% | — | 2.32B |
| BEAG | Bold Eagle Acquisition Cor-A | $10.61 | +0.00% | 21.3 | 168.92M |
| CEPF | Cantor Equity Partners-Cl A | $10.33 | +0.00% | 41.5 | 590.36M |